Cargando…
Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma
The p16 gene, encodes a key checkpoint protein p16 in the cell cycle, has been reported inactivation in a wide variety of human cancers. We have previously demonstrated high frequency of p16 alterations in primary nasopharyngeal carcinoma (NPC), xenografts and cell lines. The finding implied that in...
Autores principales: | Wang, G L, Lo, K W, Tsang, K S, Chung, N Y F, Tsang, Y S, Cheung, S T, Lee, J C K, Huang, D P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374319/ https://www.ncbi.nlm.nih.gov/pubmed/10584871 http://dx.doi.org/10.1038/sj.bjc.6690818 |
Ejemplares similares
-
Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene
por: Kato, H, et al.
Publicado: (2000) -
Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts
por: Tsang, Chi Man, et al.
Publicado: (2013) -
Restoration of p16(INK4A) protein induces myogenic differentiation in RD rhabdomyosarcoma cells
por: Urashima, M, et al.
Publicado: (1999) -
Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice
por: Kang, Min-Jung, et al.
Publicado: (2021) -
Nasopharyngeal carcinoma – Improving cure with technology and clinical trials
por: Tsang, Raymond K.
Publicado: (2020)